Multiple Myeloma Care: Timing, Teamwork, Treatment
From HemeTalks: Conversations in Hematology Education by American Society of Hematology
May 21, 2026 · 23 min · Season 5 · Episode 23
About this episode
This episode discusses the evolving care for multiple myeloma, emphasizing the importance of teamwork and informed decision-making for patients and caregivers.
Multiple myeloma care is evolving faster than ever, with new therapies, treatment strategies, and possibilities emerging at an unprecedented pace. In this episode, hematologist Dr. Devarakonda and Kathy Giusti, founder of the Multiple Myeloma Research Foundation, come together for a candid, practical conversation about what this rapid progress means for patients, caregivers, and providers. They explore why where you’re treated matters , how timing, sequencing, and dosing decisions shape outcomes , and what it takes to be an informed patient in today’s complex care environment . Through real-world stories and clinical insight, the conversation highlights the importance of collaboration between community and academic care teams, the growing role of the patient voice in decision-making, and the need to balance cutting-edge treatment with quality of life. Whether newly diagnosed or navigating later lines of therapy, this episode offers practical guidance for making confident, informed decisions in multiple myeloma care. Key Takeaways Multiple myeloma is increasingly treatable, with patients living longer than ever. Advances in therapy are leading to remission for many patients and…
People in this episode
Guests: Dr. Devarakonda, Kathy Giusti
Topics covered
- multiple myeloma
- treatment strategies
- patient care
- teamwork in healthcare
- clinical insights
- patient voice
- quality of life
Keywords
- multiple myeloma
- treatment
- care team
- patient decisions
- survival outcomes
- therapy advancements
- caregiver involvement
Mentioned in this episode
Organizations: Multiple Myeloma Research Foundation
More episodes of HemeTalks: Conversations in Hematology Education
- Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status · June 4, 2026 · 21 min
- Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento · May 21, 2026 · 22 min
- TTP Today: Diagnosis, Management & Evolving Therapies · May 7, 2026 · 20 min
- Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring · April 16, 2026 · 25 min
- New Horizons in Smoldering Multiple Myeloma · March 19, 2026 · 26 min
- Interpreting Abnormal SPEP – Is It Just MGUS? · February 19, 2026 · 27 min
Explore listener stats, chart rankings, contacts and more on the HemeTalks: Conversations in Hematology Education podcast page.